Paul Crossett - Net Worth and Insider Trading

Paul Crossett Net Worth

The estimated net worth of Paul Crossett is at least $3 Million dollars as of 2024-11-13. Paul Crossett is the 10% Security Holder of NexgenRx Inc and owns about 8,260,500 shares of NexgenRx Inc (TSXV:NXG) stock worth over $2 Million. Paul Crossett is the 10% Security Holder of Jemtec Inc and owns about 218,600 shares of Jemtec Inc (TSXV:JTC) stock worth over $177,066. Paul Crossett is also the 10% Security Holder of PJX Resources Inc and owns about 600,000 shares of PJX Resources Inc (TSXV:PJX) stock worth over $63,000. Details can be seen in Paul Crossett's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Paul Crossett has not made any transactions after 2024-09-17 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Paul Crossett

To

Paul Crossett Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Paul Crossett owns 3 companies in total, including NexgenRx Inc (TSXV:NXG) , PJX Resources Inc (TSXV:PJX) , and Jemtec Inc (TSXV:JTC) .

Click here to see the complete history of Paul Crossett’s form 4 insider trades.

Insider Ownership Summary of Paul Crossett

Ticker Comapny Transaction Date Type of Owner
TSXV:NXG NexgenRx Inc 2024-09-17 10% Security Holder
TSXV:PJX PJX Resources Inc 2023-11-21 10% Security Holder
TSXV:JTC Jemtec Inc 2024-07-17 10% Security Holder

Paul Crossett Latest Holdings Summary

Paul Crossett currently owns a total of 3 stocks. Among these stocks, Paul Crossett owns 8,260,500 shares of NexgenRx Inc (TSXV:NXG) as of September 17, 2024, with a value of $2 Million and a weighting of 91.03%. Paul Crossett owns 218,600 shares of Jemtec Inc (TSXV:JTC) as of July 17, 2024, with a value of $177,066 and a weighting of 6.61%. Paul Crossett also owns 600,000 shares of PJX Resources Inc (TSXV:PJX) as of November 21, 2023, with a value of $63,000 and a weighting of 2.35%.

Latest Holdings of Paul Crossett

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
TSXV:NXG NexgenRx Inc 2024-09-17 8,260,500 0.30 2,436,848
TSXV:JTC Jemtec Inc 2024-07-17 218,600 0.81 177,066
TSXV:PJX PJX Resources Inc 2023-11-21 600,000 0.11 63,000

Holding Weightings of Paul Crossett


Paul Crossett Form 4 Trading Tracker

According to the SEC Form 4 filings, Paul Crossett has made a total of 87 transactions in NexgenRx Inc (TSXV:NXG) over the past 5 years, including 87 buys and 0 sells. The most-recent trade in NexgenRx Inc is the acquisition of 20,000 shares on September 17, 2024, which cost Paul Crossett around $5,000.

According to the SEC Form 4 filings, Paul Crossett has made a total of 23 transactions in Jemtec Inc (TSXV:JTC) over the past 5 years, including 23 buys and 0 sells. The most-recent trade in Jemtec Inc is the acquisition of 500 shares on July 17, 2024, which cost Paul Crossett around $350.

According to the SEC Form 4 filings, Paul Crossett has made a total of 48 transactions in PJX Resources Inc (TSXV:PJX) over the past 5 years, including 47 buys and 1 sells. The most-recent trade in PJX Resources Inc is the sale of 100,000 shares on November 21, 2023, which brought Paul Crossett around $12,000.

Insider Trading History of Paul Crossett

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Paul Crossett Trading Performance

GuruFocus tracks the stock performance after each of Paul Crossett's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Paul Crossett is 12.48%. GuruFocus also compares Paul Crossett's trading performance to market benchmark return within the same time period. The performance of stocks bought by Paul Crossett within 3 months outperforms 98 times out of 173 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Paul Crossett's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Paul Crossett

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
117 out of 192 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 6.7 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 5.49 LIMIT LIMIT LIMIT LIMIT LIMIT

Paul Crossett Ownership Network

Ownership Network List of Paul Crossett

No Data

Ownership Network Relation of Paul Crossett

Insider Network Chart

Paul Crossett Owned Company Details

What does NexgenRx Inc do?

Who are the key executives at NexgenRx Inc?

Paul Crossett is the 10% Security Holder of NexgenRx Inc. Other key executives at NexgenRx Inc include and Senior Officer Kelly Tyler Ehler .

NexgenRx Inc (TSXV:NXG) Insider Trades Summary

Over the past 18 months, Paul Crossett made 4 insider transaction in NexgenRx Inc (TSXV:NXG) with a net purchase of 54,000. Other recent insider transactions involving NexgenRx Inc (TSXV:NXG) include a net sale of 13,500 shares made by Kelly Tyler Ehler ,

In summary, during the past 3 months, insiders sold 0 shares of NexgenRx Inc (TSXV:NXG) in total and bought 35,000 shares, with a net purchase of 35,000 shares. During the past 18 months, 127,500 shares of NexgenRx Inc (TSXV:NXG) were sold and 168,000 shares were bought by its insiders, resulting in a net purchase of 40,500 shares.

NexgenRx Inc (TSXV:NXG)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

NexgenRx Inc Insider Transactions

No Available Data

Paul Crossett Mailing Address

Above is the net worth, insider trading, and ownership report for Paul Crossett. Currently GuruFocus does not have mailing address information for Paul Crossett.